Journey Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $286K | Sell |
3,656
-1,039
| -22% | -$81.3K | 0.02% | 245 |
|
|
2025
Q1 | $340K | Sell |
4,695
-345
| -7% | -$25K | 0.03% | 224 |
|
|
2024
Q4 | $466K | Hold |
5,040
| – | – | 0.06% | 159 |
|
|
2024
Q3 | $466K | Hold |
5,040
| – | – | 0.06% | 159 |
|
|
2024
Q2 | $466K | Sell |
5,040
-3,799
| -43% | -$351K | 0.06% | 158 |
|
|
2024
Q1 | $845K | Sell |
8,839
-3,455
| -28% | -$330K | 0.1% | 122 |
|
|
2023
Q4 | $937K | Sell |
12,294
-750
| -6% | -$57.2K | 0.13% | 111 |
|
|
2023
Q3 | $904K | Sell |
13,044
-1,525
| -10% | -$106K | 0.14% | 111 |
|
|
2023
Q2 | $1.37M | Sell |
14,569
-2,810
| -16% | -$265K | 0.2% | 95 |
|
|
2023
Q1 | $1.44M | Sell |
17,379
-5,810
| -25% | -$481K | 0.23% | 97 |
|
|
2022
Q4 | $1.73M | Sell |
23,189
-2,825
| -11% | -$211K | 0.43% | 64 |
|
|
2022
Q3 | $2.15M | Buy |
26,014
+300
| +1% | +$24.8K | 0.55% | 50 |
|
|
2022
Q2 | $2.56M | Sell |
25,714
-2,070
| -7% | -$206K | 0.59% | 44 |
|
|
2022
Q1 | $3.27M | Hold |
27,784
| – | – | 0.83% | 29 |
|
|
2021
Q4 | $3.6M | Hold |
27,784
| – | – | 0.99% | 25 |
|
|
2021
Q3 | $3.15M | Sell |
27,784
-1,465
| -5% | -$166K | 1.02% | 25 |
|
|
2021
Q2 | $3.03M | Sell |
29,249
-90
| -0.3% | -$9.32K | 0.96% | 28 |
|
|
2021
Q1 | $2.45M | Sell |
29,339
-190
| -0.6% | -$15.9K | 0.86% | 31 |
|
|
2020
Q4 | $2.69M | Buy |
+29,529
| New | +$2.69M | 1.01% | 27 |
|